摘要
鉴于阿比多尔可作为新型冠状病毒感染肺炎患者临床治疗的候选药物之一,该文基于生物医药领域颇有价值的情报载体——专利数据,进行申请趋势、专利权人及技术方向等多维分析,梳理出阿比多尔药物相关的国内外专利布局概况以及我国专利权人面临的竞争格局,以期为我国药物研发攻关工作提供信息支撑。分析结果显示,阿比多尔核心专利已经过期,我国企业生产阿比多尔并不存在专利壁垒,但是目前生产厂家的有效专利保护薄弱,可以跟进药物新用途方向的专利布局。
Abidol is one of the candidate drugs that can be used in clinical treatment of patients with COVID-19.Based on patent data,a valuable information carrier in the field of biomedicine,this paper conducts a multidimensional analysis of application trends,R&D institutions,technical directions,and sorts out the general situation of domestic and foreign patent layout.This paper provides information support for drugs research and development.
作者
赵萍
郑丽丽
赵亚娟
Zhao Ping;Zheng Lili;Zhao Yajuan(National Science Library,Chinese Academy of Sciences,Beijing 100190,China)
出处
《科学观察》
2020年第5期18-24,共7页
Science Focus